Cargando…
Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) epidemic is spreading worldwide. Shufeng Jiedu capsule (SFJDC) is a commonly used drug in the treatment of COVID-19. However, there is insufficient evidence for clinical efficacy and safety. METHODS: Two authors will independently search the Chinese Na...
Autores principales: | Ma, Li, Song, Ji-Ni, Song, Yan-Ping, Zhao, Lin-Tao, Chen, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738147/ https://www.ncbi.nlm.nih.gov/pubmed/33327256 http://dx.doi.org/10.1097/MD.0000000000023293 |
Ejemplares similares
-
Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020) -
Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Ren, Huijun, et al.
Publicado: (2021) -
The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis
por: Sheng, Xiaodi, et al.
Publicado: (2022) -
Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Xia, Ru-yu, et al.
Publicado: (2020) -
Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
por: Han, Yanqi, et al.
Publicado: (2023)